Unlocking the Potential: Semaglutide’s Impact on Alzheimer’s and Parkinson’s Disease in Animal Models
Semaglutide (SEM), a glucagon-like peptide-1 receptor agonist, has garnered increasing interest for its potential therapeutic effects in neurodegenerative disorders such as Alzheimer’s disease (AD) and Parkinson’s disease (PD). This review provides a comprehensive description of SEM’s mechanism of a...
保存先:
| 主要な著者: | , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
MDPI AG
2024-06-01
|
| シリーズ: | Current Issues in Molecular Biology |
| 主題: | |
| オンライン･アクセス: | https://www.mdpi.com/1467-3045/46/6/354 |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|